Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Biome Australia Ltd ( (AU:BIO) ) has issued an announcement.
Biome Australia Limited has announced that its Annual General Meeting (AGM) will be held on 26 November 2025, with the closing date for director nominations set for 8 October 2025. This announcement is part of the company’s compliance with ASX Listing Rules and its Constitution. The AGM will provide shareholders with further details in a separate Notice of Meeting. This meeting is a significant event for stakeholders as it will address company governance and future strategic directions.
The most recent analyst rating on (AU:BIO) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Limited develops, licenses, commercializes, and markets innovative, evidence-based live biotherapeutics (probiotics) and complementary medicines supported by clinical research. The company aims to improve health outcomes and quality of life by making products accessible through professional health channels. Incorporated in 2018, Biome distributes locally and internationally, partnering with leading microbiome research organizations to produce unique products with innovative delivery technologies. Their flagship Activated Probiotics® range is supported by clinical trials and helps manage various health concerns.
Average Trading Volume: 412,429
Technical Sentiment Signal: Sell
For an in-depth examination of BIO stock, go to TipRanks’ Overview page.